An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer

PURPOSE: To study the safety and clinical efficacy on combination of irreversible electroporation and allogeneic natural killer cell therapy for treating Stage III/IV pancreatic cancer, evaluating median progression free survival (PFS), and overall survival (OS). RESULTS: Adverse events of all patie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Lin, Mao, Alnaggar, Mohammed, Liang, Shuzhen, Wang, Xiaohua, Liang, Yinqing, Zhang, Mingjie, Chen, Jibing, Niu, Lizhi, Xu, Kecheng
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2017
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5731915/
https://ncbi.nlm.nih.gov/pubmed/29254205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21974
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky